These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T, Zhu L, Chen L, Xu X. J Chem Inf Comput Sci; 2003 Sep; 43(1):273-87. PubMed ID: 12546563 [Abstract] [Full Text] [Related]
6. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y, Xiao J, Guo Z, Chu F, Cheng Y, Wu S. Bioorg Med Chem; 2005 Sep 15; 13(18):5424-34. PubMed ID: 15963726 [Abstract] [Full Text] [Related]
11. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II. Huang H, Pan X, Tan N, Zeng G, Ji C. Eur J Med Chem; 2007 Mar 15; 42(3):365-72. PubMed ID: 17118494 [Abstract] [Full Text] [Related]
12. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ, Li YX, Zhu XL, Xi Z, Niu C, Wan J, Zhang L, Yang GF. J Chem Inf Model; 2007 Mar 15; 47(6):2335-44. PubMed ID: 17887745 [Abstract] [Full Text] [Related]
13. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies. Thaimattam R, Daga P, Rajjak SA, Banerjee R, Iqbal J. Bioorg Med Chem; 2004 Dec 15; 12(24):6415-25. PubMed ID: 15556759 [Abstract] [Full Text] [Related]
14. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA, Gadad AK. J Med Chem; 2006 Jan 26; 49(2):475-89. PubMed ID: 16420035 [Abstract] [Full Text] [Related]